These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of eye burns with a polyvalent proteolytic inhibitor].
    Author: Gundorowa RA, Bordjugowa GG, Choroschilowa-Maslewa IP, Tschesnokowa NB, Ilatowskaja LW, Sosulina NE.
    Journal: Klin Monbl Augenheilkd; 1990 Jul; 197(1):1-5. PubMed ID: 2395296.
    Abstract:
    The present paper reports the results of a study on the use of a polyvalent proteolysis inhibitor (Gordox), the active agent of which is aprotinin, in early stages of ocular burn injuries. Following experimental corneal burns, Gordox influenced the activity of proteolytic enzymes in ocular tissue and morphologic changes in the cornea. Various administration methods were studied--instillation, and subconjunctival and intravenous injection. The preparation reduced the activity of proteolytic enzymes in the burned region of the cornea by a factor of two and led to "stages" in healing processes, thus preventing severe complications following ocular burns. In 98 patients (152 eyes) with ocular burn injuries, Gordox was found to be highly efficacious: in particular, it reduced the severity of inflammation in ocular tissues and considerably decreased the incidence of corneal perforations.
    [Abstract] [Full Text] [Related] [New Search]